Influence of the teaching program on the learning in knowledge and practice of osteonecrosis of the jaws produced by antireasorptives in dental students of the Principality of Asturias (Spain)

Abstract

BackgroundThis study aims to evaluate the influence of changes in the teaching contents on medication-related osteonecrosis of the jaw may have on the knowledge and the capacity for practical case resolution about this pathology.Material and MethodsA cross-sectional descriptive study was conducted through a survey divided into four sections: degree of means of knowledge acquisition, habitual practice and ability to solve clinical cases. The total number of respondents (n = 225) was divided into two groups: Group A (Year 2015-2016) and Group B (Year 2016-2017). The students in Group B received more teaching content on the subject than group A.ResultsA total of 175 survey responses were collected. The internet was the preferred tool for continuing education in both groups. The best known bisphosphonates (BPs) were Alendronate (Fosamax®: 56.9% Group A, 67.5% Group B) and Zoledronic Acid (Zometa®: 56.9% Group A, 51.8% Group B). A low percentage of students (37.9% Group A, 43.4% Group B) acknowledged the existence of other drugs that could also cause osteonecrosis of the jaws. Regarding the correct resolution of practical cases, the respondents of Group B reached a significantly higher score (5.67) than the score observed in Group A (4.04). ConclusionsTraining on medication-related osteonecrosis among dental students is susceptible to improvement. Introducing minor changes in the teachings allows this goal to be successfully achieved. Key words:Osteonecrosis of the jaw (ONJ), bisphosphonate-related osteonecrosis of the jaws (BRONJ), medication-related osteonecrosis of the jaw (MRONJ), dental education.

Knowledge of dental professionals and Dental students on bisphosphonates and bisphosphonate-associated osteonecrosis of the jaws

“…Almost 80% of the participants answered that they knew the bisphosphonates, similarly to the results of other studies (60% to 80%) (De Lima et al, 2015;Escobedo et al, 2017;Al-Eid et al, 2020;Al-Maweri et al, 2020;Almousa et al, 2021).…”

“…Although the need for dissemination of information about bisphosphonates and BAONJ for the dental community is evident, few studies have been directed to understand the knowledge of dental students and professionals about the subject, in In the present study males and females showed similar knowledge about bisphosphonates and BAONJ, similarly to the results of Escobedo et al (2017). The present sample was composed mainly by dental students and participants derived from private dental schools, in contrast to the sample studied by De Lima et al (2015).…”

“…The present sample was composed mainly by dental students and participants derived from private dental schools, in contrast to the sample studied by De Lima et al (2015). Some studies have included only dental students (Escobedo et al, 2017;Rosella et al, 2017), while others have included only graduated dental professionals (Alhussain et al, 2015;Vinitzky-Brener et al, 2017;Hristamyan-Cilev et al, 2019;Al-Eid et al, 2020;Al-Maweri et al, 2020;Alqhtani et al, 2020;Arnaud et al, 2021;Ozkan et al, 2021). More recently, Franchi et al (2020) have showed the results derived from a sample of medical students and Miranda-Silva et al ( 2020) compared the results derived from dentists, physicians and nurses.…”

Teledentistry as a Supportive Tool for Dentists in Diagnosing MRONJ in Northern Cyprus

“…In previously reported studies, in the evaluation of knowledge regarding the therapeutic indications for bisphosphonates, antiresorptive, or antiangiogenetic, osteoporosis was the most stated answer by participants followed by cancer treatment for bone metastases and multiple myeloma and osteogenesis imperfecta [ 13 , 33 , 34 , 37 ]. These previous reports verify the results of this survey that osteoporosis was the main therapeutic indication stated by the dentists, followed by cancer treatment of patients with metastatic bone tumors, multiple myeloma, and osteogenesis imperfecta and anemia.…”

İntraoral Bölgeye Uygulanan Girişimsel İşlemler ile İlaç Kullanımına Bağlı Çenelerde Görülen Osteonekroz Arasındaki İlişki Konusunda Diş Hekimliği Öğrencilerinin Bilgi Düzeylerinin ve Farkındalığının Ölçülmesi

“…AAOMS, bisfosfanata bağlı çene osteonekrozunun (BRONJ) terimi ve antirezorptif ajan kaynaklı osteonekroz (ARONJ) terimi yerine; ilaca bağlı çene kemiği osteonekrozu (MRONJ) teriminin kullanılmasını önermiştir. [9][10][11] Bu değişim; antirezorptif ve antianjiogenik ilaç tedavisiyle ilişkili maksilla ve mandibulayı içeren osteonekroz olgularının artan sayısı ile desteklenmektedir. 12 Bu tanımına göre hastalar;…”